Internal Medicine

Two-year data from the phase 3 ADVANCE study of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis show that more frequent dosing yields greater improvements, and that treatment with the drug is associated with a reduction in relapse rates, slower disease progression, and fewer T2 lesions compared to placebo.

A multipronged approach built around screening, education, community outreach, and expanded access to care is critical to reducing the prevalence of hepatitis C in the African-American community.

Researchers used a combination of stem cells, growth factors, and scaffold to grow human cartilage, which they hope will heal patients with osteoarthritis and other joint pain.

A cancer analgesic has been awarded fast track status by the US Food and Drug Administration.

Literature review by the AAN shows that oral and oral spray forms of medical marijuana effectively treat some symptoms of MS, but there is little evidence to support efficacy in treating other neurologic diseases such as Parkinson's disease, epilepsy, and Tourette syndrome.

Patients treated with ofatumumab, an anti-B cell antibody, for 24 weeks showed a significant reduction in disease activity, as measured by the appearance of new brain lesions.

In a phase 4 trial, combination salmeterol/fluticasone produced similar relief from COPD as indacaterol.

The development of epilepsy and subsequent seizures was prevented in animal models following the use of losartan, a common hypertension drug.

In an April 2014 study published in Diabetologia, researchers in Germany reviewed phase 3 clinical trial data from all pharmaceutical companies that produced GLP-1 receptor agonists and DPP-4 inhibitors.

A device recently approved by the US Food and Drug Administration to treat surgery used in combination surgery with a separate implantable system may completely eliminate surgery.

Do National Prescription Drug Takeback Programs really make an impact on opioid misuse and diversion? Why doesn't the DEA go after people who overdose on opioids that were probably diverted?

Children with irritable bowel syndrome are 4 times more likely to have co-occurring celiac disease, according to research published in JAMA Pediatrics.

Although they are revolutionary for the treatment of various gastric acid-related disorders, proton pump inhibitors may be linked to interstitial nephritis, according to research published in Kidney International.

Among other tobacco products, e-cigarettes, cigars, nicotine gels, and hookah tobacco will be regulated by the US Food and Drug Administration, the agency announced Thursday.

The FDA has approved the first human papillomavirus (HPV) DNA test for primary cervical cancer screening.

Over a study period of one year, Zonegran (zonisamide) was well tolerated in children aged 6-18 years.

New data from the ORBIT-AF registry indicate that obstructive sleep apnea increases the chance of hospitalization and major bleeding for people with atrial fibrillation.

Thiazide and angiotensin II receptor blocker (ARB) combination therapy may cause hyponatremia in elderly patients, according to a study published in The Japanese Society of Internal Medicine.

Underwater inferential current therapy significantly improves overall hand function in patients whose psoriatic arthritis affects their hands, according to a study published in the April issue of International Journal of Physiotherapy and Research.

The US Food and Drug Administration is now requiring the drug labels of corticosteroids injected into the epidural space of the spine to include a warning on the risk of loss of vision, stroke, paralysis, and death.